Apyx Medical Corp Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Apyx Medical Corp (APYX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $15.82 million for the 3-month period ending 2019-03-31, per its 10-Q/A filed 2020-05-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-05-08
- Apyx Medical Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was $15.82M.
- Apyx Medical Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was -$1.31M.
- Apyx Medical Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was -$2.95M.
- Apyx Medical Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $5.80M.
- Apyx Medical Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was -$4.57M, a 276.26% decline from fiscal 2016.
- Apyx Medical Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was $2.59M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | $15.82M 10-Q/A · filed 2020-05-08 | $15.95M 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $5.80M 10-K · filed 2019-03-14 | ||||
| 2018-09-30 | $30.00M 10-Q/A · filed 2020-05-08 | ||||
| 2018-06-30 | -$2.13M 10-Q · filed 2018-08-01 | ||||
| 2018-03-31 | -$1.31M 10-Q/A · filed 2020-05-08 | ||||
| 2017-12-31 | -$4.57M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | -$5.04M 10-Q/A · filed 2020-05-08 | ||||
| 2017-06-30 | -$4.16M 10-Q · filed 2018-08-01 | ||||
| 2017-03-31 | -$2.95M 10-Q · filed 2018-05-15 | ||||
| 2016-12-31 | $2.59M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |